Literature DB >> 14604126

Pharmacological treatment of acute ischemic stroke.

Janet Murphy1.   

Abstract

Ischemic stroke is devastating. It is the third leading cause of death in the United States. Each year, 480,000 people fall victim to ischemic stroke, which is estimated to cost 71.8 billion dollars (Hinkle JL, Bowman L. J Neurol Nurs. 2003;35:1-8. New treatment is available. Acute ischemic stroke is no longer considered an accident resulting in damage that must simply be dealt with. Now termed a brain attack, like a heart attack it must be treated immediately. Education is key to improving outcomes. Health care professionals must be trained to recognize early signs and symptoms of stroke. The public must be educated to understand the urgency of early evaluation once symptoms of stroke occur Brown M. Clin Med. 2001; 1:60-65). Television commercials, billboards, and public health lectures can be advantageous in a campaign to educate about stroke and the need to seek help immediately when experiencing symptoms, to halt the ischemic damage Brown M. Clin Med. 2001; 1:60-65.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604126     DOI: 10.1097/00002727-200310000-00003

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  3 in total

Review 1.  Cell adhesion molecules and ischemic stroke.

Authors:  Gokhan Yilmaz; D Neil Granger
Journal:  Neurol Res       Date:  2008-10       Impact factor: 2.448

2.  Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: nicotiflorin and JAK2/STAT3 pathway.

Authors:  Guang-Qiang Hu; Xi Du; Yong-Jie Li; Xiao-Qing Gao; Bi-Qiong Chen; Lu Yu
Journal:  Neural Regen Res       Date:  2017-01       Impact factor: 5.135

3.  Study on the mechanism of JAK2/STAT3 signaling pathway-mediated inflammatory reaction after cerebral ischemia.

Authors:  Yuquan Wu; Juan Xu; Jing Xu; Wei Zheng; Qingyong Chen; Deming Jiao
Journal:  Mol Med Rep       Date:  2018-01-24       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.